Zurueck zur Suche

Reporte zur Charge U8156AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

3Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MI 2 PA 1

VAERS 2726702

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge U8156AA

moderat
Staat
MI
Alter
76,0
Geschlecht
F
Eingang
21.12.2023
Impfdatum
19.10.2023
Beginn
24.10.2023
Tage bis Beginn
5,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Arthralgia Back pain Dyspnoea Pain

Symptomtext

Reported Symptoms: Narrative: Patient telephoned the clinic and reported that her shoulder became sore and began to radiate into her back. She states that two days after the vaccine (Sunday 10/22/2023) her back was so sore that breathing was difficult. However at the time of the telephone conversation the severity has subsided. Other Relevant HX: Other:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2713560

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge U8156AA

moderat
Staat
PA
Alter
68,0
Geschlecht
M
Eingang
14.11.2023
Impfdatum
30.10.2023
Beginn
30.10.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dyspnoea Swelling face

Symptomtext

experienced swelling of his face; shortness of breath; Initial information received on 01-Nov-2023 regarding an unsolicited valid non-serious case received from a physician. This case involves 68 years old male patient who experienced swelling of his face and shortness of breath after receiving influenza quadrival A-b high dose HV vaccine [fluzone high-dose quadrivalent]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. List concomitant or: no other vaccines On 30-Oct-2023, the patient received a dose of 0.7 mL of suspect influenza quadrival A-b high dose HV vaccine (lot U8156AA, expiry date- 30-JUN-2024) (with an unknown strength, formulation) via intramuscular route in the left upper arm for Immunisation. On 30-OCT-2023, (latency- same day), the patient developed swelling of his face (swelling face) and shortness of breath (dyspnoea) following the administration of influenza quadrival A-b high dose HV vaccine. Reportedly, There was no apparent rash. The patient contacted the physician the next day and was instructed to take Benadryl. Patient noticed improvement with Benadryl. Patient was seen by the physician today, 01NOV2023. The physician was not able to see any swelling on the patient's face. The patient's symptoms lasted 2 days. The patient noted that this was the first time he had received a flu vaccine. Action taken was not applicable. Treatment: Physician recommended patient take Benadryl for symptoms. Patient noticed some improvement after taking Benadryl. At time of reporting, the outcome was Recovered / Resolved on 01-Nov-2023 for both the events.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2701484

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge U8156AA

gering
Staat
MI
Alter
78,0
Geschlecht
F
Eingang
25.10.2023
Impfdatum
24.10.2023
Beginn
24.10.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered No adverse event

Symptomtext

no adverse event- patient recieved a flu shot while living at one AFC home and then moved to a new AFC home and recieved a second flu shot 1 month later. It was not communicated between AFC homes that she had already recieved her flu shot. I traveled to both AFC homes to do yearly flu shots and covid boosters.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
no
Vorherige Impfungen
-